Biomedical Importance of Indoles

Dolle, 1999, Comprehensive survey of combinatorial library synthesis: 1998, J. Comb. Chem., 1, 235, 10.1021/cc9900192

Franzen, 2000, Recent advances in the preparation of heterocycles on solid support: A review of the literature, J. Comb. Chem., 2, 195, 10.1021/cc000002f

Dolle, 2001, Comprehensive survey of combinatorial library synthesis: 2000, J. Comb. Chem., 3, 477, 10.1021/cc010049g

Hanessian, 1997, Design and synthesis of conformationally constrained amino acids as versatile scaffolds and peptide mimetics, Tetrahedron, 53, 12789, 10.1016/S0040-4020(97)00476-6

Radwanski, 1995, Tryptophan biosynthesis and metabolism: Biochemical and molecular genetics, Plant Cell, 7, 921

Jones, 1982, Tryptamine: A neuromodulator or neurotransmitter in mammalian brain?, Progress Neurobiol., 19, 117, 10.1016/0301-0082(82)90023-5

Berger, 2009, The expanded biology of serotonin, Annu. Rev. Med., 60, 335, 10.1146/annurev.med.60.042307.110802

Chilton, 1979, Psilocin, bufotenine and serotonin: Historical and biosynthetic observations, J. Psychedelic Drugs, 11, 61, 10.1080/02791072.1979.10472093

Fox, 2005, Resolution of concentration–response differences in onset of effect between subcutaneous and oral sumatriptan, Headache, 45, 632, 10.1111/j.1526-4610.2005.05129a.x

Generali, 2009, Off-label drug uses—Ondansetron: Postanesthetic shivering, Hospital Pharmacy, 44, 670, 10.1310/hpj4408-670

Horton, 2001, Lotronex and the FDA: A fatal erosion of integrity, Lancet, 375, 1544, 10.1016/S0140-6736(00)04776-0

Saxton, J.E. (2008). The Chemistry of Heterocyclic Compounds Part 4, John Wiley & Sons.

Mehta, 1995, Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage, Carcinogenesis, 16, 399, 10.1093/carcin/16.2.399

Cohen, S. (1964). The Beyond Within: The LSD Story, Atheneum.

Ferreira, 1971, Indomethacin and aspirin abolish prostaglandin release from the spleen, Nat. New Biol., 231, 237, 10.1038/newbio231237a0

Johnson, 1963, The Vinca Alkaloids: A new class of oncolytic agents, Cancer Res., 23, 1390

Duflos, 2002, Novel aspects of natural and modified vinca alkaloids, Curr. Med. Chem. Anticancer Agents, 2, 55, 10.2174/1568011023354452

Beckers, 2003, Natural, semisynthetic and synthetic microtubule inhibitors for cancer therapy, Drugs Future, 28, 767, 10.1358/dof.2003.028.08.744356

Bacher, 2001, New small-molecule tubulin inhibitors, Pure Appl. Chem., 73, 1459, 10.1351/pac200173091459

Beckers, T., Baasner, S., Klenner, T., Mahboobi, S., Pongratz, H., Frieser, M., Hufsky, H., Hockemeyer, J., Fiebig, H.H., Burger, A., and Bohmer, F.D. (2001). 2-Acyl indol derivatives and their use as antitumor agents. (WO/2001/082909).

Gastpar, 1998, Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization, J. Med. Chem., 41, 4965, 10.1021/jm980228l

Medarde, 1998, Synthesis and antineoplastic activity of combretastatin analogues: Heterocombretastatins, Eur. J. Med. Chem., 33, 71, 10.1016/S0223-5234(99)80078-6

Flynn, 2002, One-pot synthesis of benzo[b]furan and indole inhibitors of tubulin polymerization, J. Med. Chem., 45, 2670, 10.1021/jm020077t

Yamamoto, 1998, Phase-I Study of E7010, Cancer Chem. Pharmacol., 42, 127, 10.1007/s002800050795

Flynn, 2001, The synthesis and tubulin binding activity of thiophene-based analogues A-4 combretastatin, Bioorg. Med. Chem. Lett., 11, 2341, 10.1016/S0960-894X(01)00436-X

Bos, 1997, Synthesis, pharmacology and therapeutic potential of 10-methoxypyrazino[1,2-a]indoles, partial agonists at the 5HT2C receptor, Eur. J. Med. Chem., 32, 253, 10.1016/S0223-5234(97)83976-1

Hudson, 1999, Harmane, norharmane and tetrahydro β-carboline have high affinity for rat imidazoline binding sites, Br. J. Pharmacol., 126, 2

Husbands, 2001, β-carboline binding to imidazoline receptors, Drug Alcohol. Depend., 64, 203, 10.1016/S0376-8716(01)00123-5

Escude, 1995, Selective Stabilization of DNA Triple Helixes by Benzopyridoindole Derivatives, J. Am. Chem. Soc., 117, 10212, 10.1021/ja00146a006

Johnson, 1943, Gliotoxin, the antibiotic principle of gliocladium fimbriatum. I. production, physical and biological properties, J. Am. Chem. Soc., 65, 2005, 10.1021/ja01250a051

Fridrichsons, 1967, The crystal structure of gliotoxin, Acta. Crystallogr., 23, 439, 10.1107/S0365110X67002944

Hara, 1995, Ras farnesyltransferase inhibitors suppress the phenotype resulting from an activated ras mutation in Caenorhabditis elegans, Proc. Natl. Acad. Sci. USA, 92, 3333, 10.1073/pnas.92.8.3333

Nagase, 1997, Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth but do not disturb lamin farnesylation and localization in human tumour cells, Br. J. Cancer, 76, 1001, 10.1038/bjc.1997.499

Inokoshi, 1992, Inhibition of farnesyl-protein transferase by gliotoxin and acetylgliotoxin, J. Antibiot., 45, 1802, 10.7164/antibiotics.45.1802

Stiborova, 2001, The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts, Biochem. Pharmacol., 62, 1675, 10.1016/S0006-2952(01)00806-1

Auclair, 1987, Multimodal action of antitumor agents on DNA: the ellipticine series, Arch. Biochem. Biophys., 259, 1, 10.1016/0003-9861(87)90463-2

Frei, 2002, Covalent binding of the anticancer drug ellipticine to DNA in V79 cells transfected with human cytochrome P450 enzymes, Biochem. Pharmacol., 64, 289, 10.1016/S0006-2952(02)01072-9

Stiborova, 2003, Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans, Chem. Res. Toxicol., 16, 38, 10.1021/tx0200818

Stiborova, 2003, DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P postlabeling, Int. J. Cancer, 107, 885, 10.1002/ijc.11511

Murray, 1993, Expression of xenobiotic metabolizing enzymes in breast cancer, J. Pathol., 169, 347, 10.1002/path.1711690312

Frei, 2004, DNA adduct formation by the anticancer drug ellipticine and its hydroxy derivatives in human breast adenocarcinoma MCF-7 Cells, Collect Czech Chem. Commun., 69, 603, 10.1135/cccc20040603

Campbell, 2004, Preparation of 3-arylmethylindoles as selective COX-2 inhibitors, Tetrahedron Lett., 45, 3793, 10.1016/j.tetlet.2004.03.068

Andersson, 2001, Pharmacology of penile erection, Pharmacol. Rev., 53, 417

Rosengren, 2009, Overexpression of Alpha2A-Adrenergic receptors contributes to type 2 diabetes, Science, 327, 217, 10.1126/science.1176827

Scott, 2000, Delavirdine: A review of its use in HIV infection, Drugs, 60, 1411, 10.2165/00003495-200060060-00013

Biswal, 2012, Indole: The molecule of diverse biological activities, Asian J. Pharm. Clin. Res., 5, 1

Yutkin, 2012, Apaziquone as an intravesical therapeutic agent for urothelial non-muscle-invasive bladder cancer, Expert Opin. Investig. Drugs., 21, 251, 10.1517/13543784.2012.646081

and Rhodes, P.H. (1996). Dictionary of Organic Compounds, Chapman & Hall.

Leneva, 2009, Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol, Antiviral Res., 81, 132, 10.1016/j.antiviral.2008.10.009

Napalkov, 2012, Therapy with perindopril: organoprotection, not just the antihypertensive effect, Kardiologiia, 52, 80

Bacher, 2006, Oxindole alkaloids from Uncaria tomentosa induce apoptosis in proliferating, G0/G1-arrested and bcl-2-expressing acute lymphoblastic leukaemia cells, Br. J. Haematol., 132, 615, 10.1111/j.1365-2141.2005.05907.x

2010, Cytotoxic effect of the pentacyclic oxindole alkaloid mitraphylline isolated from Uncaria tomentosa bark on human Ewing's sarcoma and breast cancer cell lines, Planta Med., 76, 133, 10.1055/s-0029-1186048

Prince, 2009, Panobinostat (LBH589): A novel pan-deacetylase inhibitor with activity in T cell lymphoma, Hematol. Meet. Rep., 3, 33

Mack, 2010, To selectivity and beyond, Nat. Biotech., 28, 1259, 10.1038/nbt.1724

Isaac, 2004, Review: Combining pindolol with an SSRI improves early outcomes in people with depression, Evid. Based Ment. Health, 7, 107, 10.1136/ebmh.7.4.107

Lednicer, D. (2007). The Organic Chemistry of Drug Synthesis, A John Wiley & Sons, Inc.

Klimke, 1991, Antipsychotic efficacy of the dopaminergic autoreceptor agonist EMD 49980 (Roxindol). Results of an open clinical study, Pharmacopsychiatry, 24, 107, 10.1055/s-2007-1014451

Muller, 2004, Local treatment of tendinopathies and myofascial pain syndromes with the 5-HT3 receptor antagonist tropisetron, Scand. J. Rheumatic Suppl., 119, 44, 10.1080/03009740410007032

Macor, 2001, The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist, Bioorg. Med. Chem. Lett., 11, 319, 10.1016/S0960-894X(00)00670-3

Cui, 2009, Tropisetron attenuates naloxone-induced place aversion in single-dose morphine-treated rats: role of alpha7 nicotinic receptors, Eur. J. Pharma., 609, 74, 10.1016/j.ejphar.2008.12.051

Morse, 2010, Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. The ACTG 187 and 199 study teams, Antiviral Res., 45, 47, 10.1016/S0166-3542(99)00073-X

Hart, 1963, Indomethacin: A New non-steroid anti-inflammatory agent, Br. Med. J., 2, 965, 10.1136/bmj.2.5363.965

Smyth, 1970, Indomethacin—Its rightful place in treatment, Ann. Intern. Med., 72, 430, 10.7326/0003-4819-72-3-430

DrugBank.ca. Available online:http://www.drugbank.ca/drugs/DB00328.

Arens, 1982, Detection of pericine, a new cns-active indole alkaloid from picralima nitida cell suspension culture by opiate receptor binding studies, Planta Med., 46, 210, 10.1055/s-2007-971216

Roberts, M.F., and Wink, M. (1998). Alkaloids: Biochemistry, Ecology, and Medicinal Applications, Plenum Press.

Haubrich, 1990, Pharmacology of pravadoline: A new analgesic agent, J. Pharmacol. Exp. Ther., 255, 511

Bell, 1991, Antinociceptive (aminoalkyl) indoles, J. Med. Chem., 34, 1099, 10.1021/jm00107a034

Cook, 1981, Cerebral Vasodilators, N. Engl. J. Med., 305, 1560, 10.1056/NEJM198112243052604

Arpe, H.-J., and Ullmann, F. (1985). Ullmann's Encyclopedia of Industrial Chemistry, Wiley-VCH. [5th ed.].

Lynn, 2006, Cruciferous vegetables and colo-rectal cancer, Proc. Nutr. Soc., 65, 135, 10.1079/PNS2005486

Dashwood, 1989, Quantitative inter-relationships between aflatoxin B1 carcinogen dose, indole-3-carbinol anti-carcinogen dose, target organ DNA adduction and final tumor response, Carcinogenesis, 10, 175, 10.1093/carcin/10.1.175

Ho, 2012, I3C and ICZ inhibit migration by suppressing the EMT process and FAK expression in breast cancer cells, Mol. Med. Rep., 7, 384, 10.3892/mmr.2012.1198

Chang, 2005, 3,3′-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice, Carcinogenesis, 26, 771, 10.1093/carcin/bgi018

Rahman, 2006, Gene expression profiling revealed survivin as a target of 3,3′-Diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells, Cancer Res., 66, 4952, 10.1158/0008-5472.CAN-05-3918

Benninghoff, 2013, The role of estrogen receptor β in transplacental cancer prevention by indole-3-Carbinol, Cancer Prev. Res., 6, 339, 10.1158/1940-6207.CAPR-12-0311

Liu, 2009, Feeding tomato and broccoli powders enriched with bioactives improves bioactivity markers in rats, J. Agric. Food Chem., 57, 7304, 10.1021/jf901926b

Kim, 2005, Targets for indole-3-carbinol in cancer prevention, J. Nutr. Biochem., 16, 65, 10.1016/j.jnutbio.2004.10.007

Shorey, 2012, 3,3′-Diindolylmethane induces G1 arrest and apoptosis in human acute T-Cell lymphoblastic leukemia cells, PLoS One, 7, e34975, 10.1371/journal.pone.0034975

Tsai, 2010, Suppression of inflammatory mediators by cruciferous vegetable-derived indole-3-carbinol and phenylethyl isothiocyanate in lipopolysaccharide-activated macrophages, Mediat. Inflamm., 2010, 293642, 10.1155/2010/293642

Zhang, 2006, Methyl-3-indolylacetate inhibits cancer cell invasion by targeting the MEK1/2-ERK1/2 signaling pathway, Mol. Cancer Ther., 5, 3285, 10.1158/1535-7163.MCT-06-0240

Jeffery, 2009, Physiological effects of broccoli consumption, Phytochem. Rev., 8, 283, 10.1007/s11101-008-9106-4

Shin, 2011, Indole-containing fractions of Brassica rapa inhibit inducible nitric oxide synthase and pro-inflammatory cytokine expression by inactivating nuclear factor-κB, J. Med. Food., 14, 1527, 10.1089/jmf.2011.1611

Almagro, 2013, Synergistic and cytotoxic action of indole alkaloids produced from elicited cell cultures of catharanthus roseus, Pharm. Biol., 51, 304, 10.3109/13880209.2012.722646

Yu, 2013, Pharmacological actions of multi-target-directed evodiamine, Molecules, 18, 1826, 10.3390/molecules18021826

Shittu, 2010, Glucose uptake stimulatory effect of akuammicine from Picralima nitida (Apocynaceae), Phytochem. Lett., 3, 53, 10.1016/j.phytol.2009.11.003

Savina, 2011, Structure, bioactivity and synthesis of natural products with hexahydropyrrolo[2,3-b]indole, Chem. Eur. J., 17, 1388, 10.1002/chem.201001451

Bialonska, 2009, Aplysinopsins—Marine indole alkaloids: Chemistry, bioactivity and ecological significance, Mar. Drugs, 7, 166, 10.3390/md7020166

Longeon, 2011, Bioactive indole derivatives from the south pacific marine sponges rhopaloeides odorabile and hyrtios sp., Mar. Drugs., 9, 879, 10.3390/md9050879

Bharate, 2012, A chemistry and biology of fascaplysin, a potent marine-derived CDK-4 inhibitor, Mini. Rev. Med. Chem., 12, 650, 10.2174/138955712800626719

Mollica, 2012, Synthesis and bioactivity of secondary metabolites from marine sponges containing dibrominated indolic systems, Molecules, 17, 6083, 10.3390/molecules17056083

Yang, 2013, Isolation, Characterization, and bioactivity evaluation of 3-((6-Methylpyrazin-2-yl)methyl)-1H-indole, a new alkaloid from a deep-sea-derived actinomycete Serinicoccus profundi sp. nov., Mar. Drugs, 11, 33, 10.3390/md11010033

Baker, 1974, Tyrian purple: An ancient dye, a modern problem, Endeavour, 33, 11, 10.1016/0160-9327(74)90003-9

Baker, 1973, Chemistry of the indoleninones. II. Isolation from the hypobranchial glands of marine molluscs of 6-bromo-2,2-dimethylthioindolin-3-one and 6-bromo-2-methylthioindoleninone as alternative precursors to Tyrian purple, Aust. J. Chem., 26, 2153, 10.1071/CH9732153

Westley, 2010, Histomorphology of the hypobranchial gland in Dicathais orbita (Gmelin, 1791) (Neogastropoda: Muricidae), J. Moll. Stud., 76, 186, 10.1093/mollus/eyp056

Benkendorff, 2013, Natural product research in the australian marine invertebrate dicathais orbita, Mar. Drugs, 11, 1370, 10.3390/md11041370

Devi, 2010, The Sponge-associated bacterium bacillus licheniformis SAB1: A source of antimicrobial compounds, Mar. Drugs, 8, 1203, 10.3390/md8041203

Mandal, 2011, Synthesis of dragmacidin D via direct C-H couplings, J. Am. Chem. Soc., 133, 19660, 10.1021/ja209945x

Chen, 2013, Bioactive indole alkaloids and phenyl Ether derivatives from a marine-derived aspergillus sp. fungus, J. Nat. Prod., 76, 547, 10.1021/np300707x

Perchellet, 2012, Antitumor effects of synthetic 6,7-annulated-4-substituted indole compounds in L1210 leukemic cells in vitro, Anticancer. Res., 32, 4671

Thornton, 2011, Application of 6,7-indole aryne cycloaddition and Pd(0)-catalyzed Suzuki-Miyaura and Buchwald-Hartwig cross-coupling reactions for the preparation of annulated indole libraries, ACS Comb. Sci., 13, 443, 10.1021/co2000289

Xie, 2013, Metabolism and bioactivation of famitinib, a novel inhibitor of receptor tyrosine kinase, in cancer patients, Br. J. Pharmacol., 168, 1687, 10.1111/bph.12047

Roy, 2006, Synthesis of bisindolylmaleimides related to GF109203x and their efficient conversion to the bioactive indolocarbazoles, Org. Biomol. Chem., 4, 3228, 10.1039/b607504e

Zhang, 2007, Highly potent triazole-based tubulin polymerization inhibitors, J. Med. Chem., 50, 749, 10.1021/jm061142s

Jump, 2008, N-Alkoxy derivatization of indole-3-carbinol increases the efficacy of the G1 cell cycle arrest and of I3C-specific regulation of cell cycle gene transcription and activity in human breast cancer cells, Biochem. Pharmacol., 75, 713, 10.1016/j.bcp.2007.09.024

Sharma, 2009, Synthesis of bioactive spiro-2-[3′-(2′-phenyl)-3H-indolyl]-1-aryl-3-phenylaziridines and SAR studies on their antimicrobial behavior, Med. Chem. Res., 18, 383, 10.1007/s00044-008-9135-y

Chen, 2010, Rapid synthesis and bioactivities of 3-(nitromethylene)indolin-2-one analogues, Chem. Pap., 64, 673, 10.2478/s11696-010-0047-1

Cuevas, 2011, Synthesis of 1-benzyl-3-[4-(aryl-1-piperazinyl) carbonyl]-1H-indoles.Novel ligands with potential D4 dopaminergic activity, J. Chil. Chem. Soc., 56, 866, 10.4067/S0717-97072011000400009

Hosseinnia, 2012, An expeditious regioselective synthesis of novel bioactive indole-substituted chromene derivatives via one-pot three-component reaction, Bioorg. Med. Chem. Lett., 22, 5956, 10.1016/j.bmcl.2012.07.059

Zhang, 2013, Development of N-Hydroxycinnamamide-Based Histone Deacetylase Inhibitors with an Indole-Containing Cap Group, ACS Med. Chem. Lett., 4, 235, 10.1021/ml300366t

Akkoc, 2012, Design, synthesis, and biological evaluation of indole-based 1,4-disubstituted piperazines as cytotoxic agents, Turk. J. Chem., 36, 515

Singh, 2009, Design, synthesis and anticancer activities of hybrids of indole and barbituric acids—Identification of highly promising leads, Bioorg. Med. Chem. Lett., 19, 3054, 10.1016/j.bmcl.2009.04.014

Kaufmann, 2007, Antimitotic activities of 2-phenylindole-3-carbaldehydes in human breast cancer cells, Bioorg. Med. Chem., 15, 5122, 10.1016/j.bmc.2007.05.030

Zhang, 2011, Synthesis and anti-tumor activity of 2-amino-3-cyano-6-(1H-indol-3-yl)-4-phenylpyridine derivatives in vitro, Eur. J. Med. Chem., 46, 3149, 10.1016/j.ejmech.2011.03.055

Jacquemard, 2008, Synthesis of 3,5-bis(2-indolyl)pyridine and 3-[(2-indolyl)-5-phenyl]pyridine derivatives as CDK inhibitors and cytotoxic agents, Bioorg. Med. Chem., 16, 4932, 10.1016/j.bmc.2008.03.034

Nassar, 2010, Synthesis, (in vitro) antitumor and antimicrobial activity of some pyrazoline, pyridine, and pyrimidine derivatives linked to indole moiety, J. Am. Sci., 6, 463

Ding, 2005, Novel indole α-methylene-γ-lactones as potent inhibitors for AKT-mTOR signaling pathway kinases, Bioorg. Med. Chem. Lett., 15, 4799, 10.1016/j.bmcl.2005.07.050

Kamal, 2010, Synthesis of 3,3-diindolyl oxyindoles efficiently catalysed by FeCl3 and their in vitro evaluation for anticancer activity, Bioorg. Med. Chem. Lett., 20, 5229, 10.1016/j.bmcl.2010.06.152

Tiwari, 2005, Highly efficient one-pot synthesis of 1-substituted-1,2,3,4-tetrahydropyrazino[1,2-a]indoles, Tetrahedron, 61, 9513, 10.1016/j.tet.2005.07.088

Tiwari, 2006, Synthesis and antibacterial activity of substituted 1,2,3,4-tetrahydropyrazino [1,2-a] indoles, Bioorg. Med. Chem. Lett., 16, 413, 10.1016/j.bmcl.2005.09.066

Tiwari, 2006, Synthesis and antifungal activity of substituted 1,2,3,4-tetrahydropyrazino[1,2-a] indoles, Bioorg. Med. Chem., 14, 2747, 10.1016/j.bmc.2005.11.054

Wu, 2009, Synthesis and Evaluation of 3-Aroylindoles as Anticancer Agents: Metabolite Approach, J. Med. Chem., 52, 4941, 10.1021/jm900060s

Capan, 2012, Synthesis and evaluation of functionalized indoles as antimycobacterial and anticancer agents, Mol. Divers., 16, 525, 10.1007/s11030-012-9385-y

Youngsaye, 2012, Overcoming fluconazole resistance in Candida albicans clinical isolates with tetracyclic indoles, Bioorg. Med. Chem. Lett., 22, 3362, 10.1016/j.bmcl.2012.02.035

Arumugam, 2012, An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents, Bioorg. Med. Chem. Lett., 22, 1375, 10.1016/j.bmcl.2011.12.061

Yamuna, 2012, Synthesis, antimicrobial, antimycobacterial and structure-activity relationship of substituted pyrazolo-, isoxazolo-, pyrimido- and mercaptopyrimidocyclohepta[b]indoles, Eur. J. Med. Chem., 47, 228, 10.1016/j.ejmech.2011.10.046

Diana, 2011, Synthesis and Antitumor Activity of 3-(2-Phenyl-1,3-thiazol-4-yl)-1H-indoles and 3-(2-Phenyl-1,3-thiazol-4-yl)-1H-7-azaindoles, Chem. Med. Chem., 6, 1300, 10.1002/cmdc.201100078

Urgaonkar, 2010, A Concise Silylamine Approach to 2-Amino-3-hydroxy-indoles with Potent in vivo Antimalaria Activity, Org. Lett., 12, 3998, 10.1021/ol101566h

Leboho, 2009, The synthesis of 2- and 3-aryl indoles and 1,3,4,5-tetrahydropyrano[4,3-b]indoles and their antibacterial and antifungal activity, Bioorg. Med. Chem. Lett., 19, 4948, 10.1016/j.bmcl.2009.07.091

Giraud, 2009, Design, synthesis and evaluation of 3-(imidazol-1-ylmethyl)indoles as antileishmanial agents. Part II, J. Enzyme Inhib. Med. Chem., 24, 1067, 10.1080/14756360802610795

Xu, 2009, Developments of Indoles as Anti-HIV-1 Inhibitors, Curr. Pharm. Des., 15, 2120, 10.2174/138161209788489168

Ryu, 2009, Synthesis and antifungal activity of 1H-pyrrolo[3,2-g]quinoline-4,9-diones and 4,9-dioxo-4,9-dihydro-1H-benzo[f]indoles, Bioorg. Med. Chem. Lett., 19, 146, 10.1016/j.bmcl.2008.10.131